Patent · US Active

Heteroleptic iridium complexes as dopants

US11380854B2 · kind B2 · utility

2Cited by
39References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2019
Grant dateJul 5, 2022
Priority date
Expiry dateJun 26, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02E10/549
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

Novel phosphorescent heteroleptic iridium complexes with phenylpyridine and dibenzo-containing ligands are provided. Alkyl substitution at specific positions on the ligands gives rise to compounds with improved OLED properties, including saturated green emission.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.